Amedisys, Inc. AMED
Trading inactive
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Frank Morgan | RBC Capital | 92.16 $ | 100 $ | 7.84 % | 25/03/2024 |
| Brian Tanquilut | Jefferies | 91.28 $ | 90.8 $ | -0.48 % | 06/07/2023 |
| David MacDonald | Truist Financial | 128.18 $ | 150 $ | 21.82 % | 26/07/2022 |
| Justin Bowers | Deutsche Bank | 110.82 $ | 175 $ | 64.18 % | 03/07/2022 |
| Matthew Borsch | BMO Capital | 159.9 $ | 190 $ | 30.10 % | 25/02/2022 |
| Ben Hendrix | RBC Capital | 159.9 $ | 199 $ | 39.10 % | 25/02/2022 |
| Justin Bowers | Deutsche Bank | 147.93 $ | 230 $ | 82.07 % | 24/02/2022 |
| Bill Sutherland | Benchmark Co. | 147.93 $ | 175 $ | 27.07 % | 24/02/2022 |
| Scott Fidel | Stephens | 174.01 $ | 185 $ | 10.99 % | 04/11/2021 |